UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO §240.13d-2

AGBA Acquisition Limited
(Name of Issuer)

Ordinary Shares, $0.001 par value
(Title of Class of Securities)

G0120M 109
(CUSIP Number)

December 31, 2019
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(Continued on following page(s))
Page 1 of 7 Pages

(1) Does not include (a) 112,500 ordinary shares issuable upon exercise of 225,000 warrants owned by AGBA Holding Limited or (b) 22,500 ordinary shares issuable upon conversion of rights owned by AGBA Holding Limited . Each warrant is exercisable at a price of $11.50 per full share commencing on the later of (x) the completion of an initial business combination and (y) May 14, 2019, and expires 5 years after the completion of an initial business combination, or earlier upon redemption. The rights convert automatically upon the closing of a business combination.

(1) Consists of the ordinary shares owned by AGBA Holding Limited . Does not include (a) 112,500 ordinary shares issuable upon exercise of 225,000 warrants owned by AGBA Holding Limited or (b) 22,500 ordinary shares issuable upon conversion of rights owned by AGBA Holding Limited . Each warrant is exercisable at a price of $11.50 per full share commencing on the later of (x) the completion of an initial business combination and (y) May 14, 2019, and expires 5 years after the completion of an initial business combination, or earlier upon redemption. The rights convert automatically upon the closing of a business combination.

Item 1.

Room 1108, 11th Floor, Block B, New Mandarin Plaza, 14 Science Museum Road, Tsimshatsui East, Kowloon, Hong Kong

Item 2.

c/o AGBA Acquisition Limited

Room 1108, 11th Floor, Block B, New Mandarin Plaza, 14 Science Museum Road, Tsimshatsui East, Kowloon, Hong Kong

AGBA Holding Limited – 1,261,000 shares.

Samuel Chan – 1,261,000 shares. Consists of ordinary shares owned by AGBA Holding Limited .

The foregoing does not include (a) 112,500 ordinary shares issuable upon exercise of 225,000 warrants owned by AGBA Holding Limited or (b) 22,500 ordinary shares issuable upon conversion of rights owned by AGBA Holding Limited . Each warrant is exercisable at a price of $11.50 per full share commencing on the later of (x) the completion of an initial business combination and (y) May 14, 2019, and expires 5 years after the completion of an initial business combination, or earlier upon redemption. The rights convert automatically upon the closing of a business combination.

Samuel Chan has voting and dispositive power over the securities owned by AGBA Holding Limited.

AGBA Holding Limited – 21.10%

Samuel Chan – 21.10%

The foregoing percentages are based on 5,975,000 ordinary shares outstanding as of December 31, 2019.

AGBA Holding Limited – 1,261,000 shares.

Samuel Chan – 1,261,000 shares.

AGBA Holding Limited – 0 shares.

Samuel Chan – 0 shares.

AGBA Holding Limited – 1,261,000 shares.

Samuel Chan – 1,261,000 shares.

AGBA Holding Limited – 0 shares.

Samuel Chan – 0 shares.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 14, 2020

EXHIBIT 1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the ordinary shares, $0.001 par value, of AGBA Acquisition Limited, a British Virgin Islands company, and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filings.

The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13G and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate.

This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this agreement as of February 14, 2020.